Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Nephrology | Obstetrics/Gynecology (Women’s Health) | Urology | Family Medicine
Disease Category: Urinary Incontinence
Location: United States, IN
Study to confirm the efficacy of Fesoterodine 4 mg compared to 8 mg.
The purpose of this study is to compare the effectiveness of two doses of a drug called Fesoterodine and placebo (a substance that contains no active ingredient but looks identical to the study drug) for overactive bladder. In order to achieve this evaluation in an unbiased manner, you will be randomly assigned to one of 3 groups: Fesoterodine 4 mg, Fesoterodine 8 mg, or Placebo.
Patient Inclusion Criteria:
Patient Exclusion Criteria:
CW ID: 180155
Date Last Changed:
May 2, 2014
Kristen Willinger, Research RecruiterFirst Urology, PSC101 Hospital BlvdJeffersonville, IN 47130Phone: (812) 206-8166Fax: (812) 288-2612
First Urology, PSC
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
We value your privacy and your information will only be used by the research center to contact
you regarding this study.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2016 CenterWatch.